The Gerson Therapy: Juicing, Coffee Enemas & Metabolic Healing
Developed by Dr. Max Gerson in the 1920s, this intensive nutritional protocol has been used by thousands seeking to reverse chronic disease and cancer.
Vitamin D3 deficiency is associated with increased risk of at least 17 cancer types. Here's what the research shows about optimal levels and supplementation.
Vitamin D deficiency is consistently associated with higher cancer risk in observational studies. Supplementation trials show mixed results. Optimising Vitamin D status is broadly supported.
For educational purposes only — not medical advice. How we evaluate evidence →
A deep dive into alternative and integrative cancer treatment approaches.
Coffee enemas have no validated clinical evidence for detoxification or cancer treatment. Serious adverse events have been reported. This article covers the evidence and the risks.
This article examines the historical use, the claims, and the documented risks.
Always consult a qualified physician or oncologist before making any changes to your treatment plan. This article is for informational purposes only and does not constitute medical advice, a diagnosis, or a treatment recommendation.
Reviewed by
Dr. A. Ferreira, MDGeneral practitioner with integrative medicine training. Reviewed for factual accuracy. Vitamin D deficiency associations with cancer are well-established; supplementation trial results are mixed.
Last reviewed
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. Our editorial standards →
Vitamin D3 (cholecalciferol) is not merely a vitamin — it is a steroid hormone with receptors in virtually every tissue in the body, including most cancer cells. The vitamin D receptor (VDR) regulates the expression of over 2,000 genes, many of which are involved in cell proliferation, differentiation, apoptosis, and immune function — all processes central to cancer biology. The epidemiological evidence linking vitamin D deficiency to cancer risk is among the most consistent in nutritional oncology: deficiency has been associated with increased risk of at least 17 cancer types, including colorectal, breast, prostate, pancreatic, and lung cancer.
The Epidemiological Evidence. The geographic distribution of cancer mortality provides a striking natural experiment in vitamin D and cancer. Populations living at higher latitudes — with less sun exposure and lower vitamin D levels — consistently show higher rates of many cancers compared to populations at lower latitudes. A landmark analysis by Cedric and Frank Garland at UC San Diego found a striking inverse correlation between solar UVB radiation (a proxy for vitamin D synthesis) and colorectal cancer mortality across US counties — a finding that has been replicated for multiple cancer types.
Vitamin D3 exerts anticancer effects through multiple mechanisms: it promotes cellular differentiation (pushing cancer cells toward more normal, less aggressive phenotypes), inhibits cellular proliferation, induces apoptosis in cancer cells, inhibits tumor angiogenesis, modulates immune function to enhance anti-tumor surveillance, and reduces systemic inflammation. These mechanisms have been demonstrated in laboratory studies across a wide range of cancer types.
The VITAL Trial: Landmark Clinical Evidence. The VITAL trial, a large randomized controlled trial of vitamin D3 supplementation (2,000 IU daily) in over 25,000 adults, published in the New England Journal of Medicine in 2019, found no significant reduction in overall cancer incidence with vitamin D supplementation. However, it found a significant 25% reduction in cancer mortality — meaning that while vitamin D did not prevent cancer from developing, it appeared to make cancers less lethal. A subsequent analysis found that the benefit was concentrated in people with normal BMI and those who had been supplementing for at least 2 years.
Optimal Levels and Supplementation. Most vitamin D researchers in the cancer prevention field recommend maintaining serum 25(OH)D levels of 40–60 ng/mL (100–150 nmol/L) — significantly higher than the conventional 'sufficient' threshold of 20 ng/mL. Achieving these levels typically requires supplementation of 4,000–8,000 IU of vitamin D3 daily for most adults, combined with vitamin K2 (MK-7, 100–200 mcg daily) to direct calcium to bones rather than arteries. Testing serum 25(OH)D levels before and after supplementation is strongly recommended.
Personalised plan
Build a personalised plan for long-term health and prevention.
Seen a claim you want to verify?
The Claim Decoder grades the evidence behind any natural health claim — A to F, with sources.
Suggested from this article:
"High-dose vitamin C can treat cancer"
Prompted by: Vitamin D3 & Cancer: The Sunshine Hormone's Anticancer Role
Developed by Dr. Max Gerson in the 1920s, this intensive nutritional protocol has been used by thousands seeking to reverse chronic disease and cancer.
Two antiparasitic drugs — one veterinary, one human — have generated extraordinary interest in the cancer research community. Here's what the science actually shows.
Dr. Johanna Budwig's controversial protocol combining flaxseed oil and cottage cheese has attracted devoted followers for 70 years. What does the science say?